The Claim
Foot reflexology maps areas of the feet to internal organs and proposes that applying pressure to a particular zone can influence the corresponding organ.
This Investigation tests the specific mapped-organ therapeutic claim.
It does not test whether foot massage can feel relaxing, temporarily reduce anxiety, change pain perception or alter physiological measurements through ordinary sensory and autonomic pathways (involuntary nervous-system responses). Those effects can occur without the reflexology map being correct.
Where It Comes From
Modern reflexology uses charts that divide the feet into regions associated with organs and body systems. A practitioner applies pressure to selected zones and may interpret tenderness or other responses as relevant to the mapped organ.
The central empirical question is not whether touch has effects. It is whether where the foot is pressed matters in the organ-specific way the map predicts.
Why It Sounds Convincing
Massage can produce real sensations and short-term physiological changes. People may feel warmer, calmer or less painful after treatment.
That creates an easy path from a real nonspecific effect to a much more specific causal story: a change after pressing the “kidney zone” is attributed to a kidney connection, or a change after pressing the “heart zone” is attributed to a heart connection.
Small studies have even reported acute physiological differences after stimulation of zones assigned to the kidney or heart. Those findings deserve examination rather than dismissal.
The key question is whether they are robust, specific, reproducible and therapeutically meaningful.
The Short Answer
Current evidence does not support the claim that mapped foot zones reliably produce specific therapeutic effects in corresponding internal organs.
A few small experiments report acute organ-related physiological changes. A randomized study of 32 healthy adults reported a change in renal vascular resistance while the proposed kidney zone was stimulated. A 16-person trial reported a modest change in cardiac index during stimulation of the proposed heart area.
Those findings are the strongest direct evidence in favor of the mapped-zone claim.
But they are small, acute physiological studies in healthy volunteers. They do not establish that reflexology treats kidney or heart disease.
Systematic reviews find little convincing evidence that reflexology produces a specific hemodynamic effect separable from ordinary massage, and broader clinical reviews repeatedly describe heterogeneous, low-quality evidence. A recent Australian government evaluation judged most assessed clinical outcomes to have very low certainty.
How It Would Have to Work
The map predicts more than a generic massage response.
If a kidney zone is special, stimulating that zone should produce an effect on the kidney that a matched pressure treatment at a non-kidney zone does not.
The same logic should apply to other mapped organs.
The effect should replicate in adequately powered studies, survive blinding and sham controls, and eventually translate into meaningful outcomes in patients with disease—not just a transient change in a physiological surrogate.
What Actually Happens
Touch and pressure activate sensory nerves in the skin and deeper tissues. Massage can alter arousal, autonomic tone, comfort, expectation and attention.
Those pathways can change heart rate, blood pressure, anxiety, pain ratings and other outcomes without requiring a hidden anatomical map connecting one patch of foot to one internal organ.
That is why the choice of control matters so much.
A comparison with “no treatment” cannot tell us whether reflexology’s map matters. A better test uses the same amount of touch, time and attention while moving the pressure away from the claimed organ-specific zone.
What the Evidence Shows
The evidence is mixed at the level of individual small trials.
The kidney study is notable because it attempted a specific mapped-zone test and found a statistically significant acute change in renal vascular resistance.
A separate randomized 2001 trial involving 32 healthy adults reported a fall in superior mesenteric artery vascular resistance while intestinal foot zones were massaged, compared with an unrelated-zone foot treatment (within-active-arm p = 0.021). The original German-language paper was accessible at abstract level, not as a fully audited numeric table. It comes from the same research group as the kidney study, so should not be treated as definitive independent replication of therapeutic efficacy.
The heart-zone study likewise reported a modest acute cardiac-index change.
But the effect sizes, sample sizes and endpoints limit what follows. Neither study showed durable treatment of organ disease.
The 2013 systematic review specifically asked whether reflexology has a treatment-related hemodynamic effect. Seven trials reported changes in cardiovascular parameters, but most did not adequately isolate reflexology’s specific component from general massage. The review found little convincing evidence for a specific effect.
A 2014 review of objective physiological and biochemical outcomes reached a similarly cautious conclusion.
Broader clinical-effectiveness reviews contain positive and negative trials across many conditions. The 2024 Australian evidence evaluation concluded that confident conclusions could not be drawn for the assessed outcomes because certainty was predominantly very low.
The Strongest Evidence for the Claim
The strongest evidence is the small set of controlled experiments that tried to stimulate an organ-associated zone and compare it with another part of the foot.
The renal, intestinal-flow and cardiac-index experimental comparisons are therefore more directly relevant to whether the foot-zone map has measurable physiological specificity than simple relief of anxiety following a massage. Their strengths are explicit zone controls and instrumental endpoints; their weaknesses include small healthy-volunteer groups, brief observation and no verified organ-disease treatment outcome.
They create a legitimate replication target.
What they do not yet create is a demonstrated therapeutic organ pathway.
The Strongest Evidence Against It
The main counter-evidence is the failure of the broader controlled literature to produce a robust, reproducible pattern of organ-specific effects.
Systematic reviewers repeatedly identify small samples, poor controls, heterogeneous endpoints and difficulty separating reflexology from nonspecific massage.
When the evidentiary question is narrowed to “does the mapped zone itself have a specific effect?”, the support remains weak.
Common Viral Arguments
“A study changed kidney blood flow, so the kidney point is proven.”
An acute change in a surrogate measurement is interesting, but it is not proof of a stable anatomical mapping and not proof of treatment.
“Reflexology reduces anxiety or pain, therefore the organ map works.”
Those outcomes can change through touch, attention, expectation, relaxation and ordinary massage. They do not by themselves identify a specific foot-to-organ connection.
“If people feel something in the mapped zone, that shows the corresponding organ is unhealthy.”
Tenderness is not a validated diagnostic test for distant-organ disease.
“There are many positive studies, so the effect must be real.”
The number of positive papers is less important than whether the studies isolate the specific claimed mechanism, are adequately controlled and replicate.
The Reasoning Error
Surrogate-endpoint error occurs when a short-term physiological measurement is treated as equivalent to meaningful therapeutic benefit.
Overgeneralization occurs when a small effect in healthy volunteers is expanded into a claim that the same mapped zone can treat disease in the corresponding organ.
What Would Change Our Conclusion?
Replicated, preregistered trials could.
They would need credible sham controls that equalize touch and attention, prespecified organ-zone mappings, objective organ-specific endpoints, adequate sample sizes and independent replication.
Most importantly, the effect should translate from acute physiology to clinically meaningful outcomes in people with the relevant organ disease.
Evidence Status
Status: Unsupported
Evidence quality: Low
There are small positive signals worth further testing, so a universal “nothing ever happens” conclusion would be too strong. But the current evidence does not justify the central therapeutic claim.
Evidence Quality is Low because direct studies are small and systematic reviews identify substantial methodological limitations and very low certainty across much of the clinical literature.
Evidence & Sources
The evidence trail includes the recent Australian government review, systematic reviews of specific hemodynamic and broader clinical effects, and small controlled studies of kidney-, intestinal- and heart-associated foot zones.
Corrections & Updates
October 10, 2026 — evidence clarification. Added the controlled 2001 intestinal-zone Doppler result in healthy adults without treating transient blood-flow measurements as organ-disease therapy. The existing Evidence Status and Evidence Quality remain unchanged; this is an evidence-interpretation update, not a claim that previous evidence was retracted.
Last Reviewed
October 10, 2026.